JPS6171359A - Measurement of biotin and measuring agent therefor - Google Patents

Measurement of biotin and measuring agent therefor

Info

Publication number
JPS6171359A
JPS6171359A JP19429884A JP19429884A JPS6171359A JP S6171359 A JPS6171359 A JP S6171359A JP 19429884 A JP19429884 A JP 19429884A JP 19429884 A JP19429884 A JP 19429884A JP S6171359 A JPS6171359 A JP S6171359A
Authority
JP
Japan
Prior art keywords
biotin
pbs
liquid
solution
100mul
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19429884A
Other languages
Japanese (ja)
Inventor
Mitsunobu Okuyama
光伸 奥山
Hidetoshi Eguchi
江口 秀敏
Harumi Umeda
梅田 晴美
Ryuichi Kawahara
川原 隆一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP19429884A priority Critical patent/JPS6171359A/en
Publication of JPS6171359A publication Critical patent/JPS6171359A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555Red blood cell
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To enable measurement of biotin quantity with a small quantity of testing liquid agent, by adding avidin and bonding carrier of protein biotinide and comparing thus aggregated matter with the standard solution of biotin. CONSTITUTION:0.01M phosphoric acid buffered physiologic salin solution (PBS) of pH 5-8 is introduced into each hole of U-bottomed of N-hydroxyplate 96 with a quantity 25-100mul. Next, lesting liquid agent or biotin standard solution of 25-100mul is introduced into the holes of the 1st row and the liquid is subjected to dilution by half concentration. Next, all the holes are filled with 5-50ng/ml of 25-100mul of avidin PBS solution and 25-100mul of 0.1-0.5% PBS floating liquid of rea blood cells aggregated with protein biotinide and the mixture is provided with through agitation. After 1-24hr the liquid is tested for the aggrogation condition, inhibition condition of standard liquid and testing agent is compared and an biotin concentration of the test agent is obtained. In the present invention, in order to prevent a non-singular reoction, it is preferable that the PBS is added with 0.05-1% serum albumin or protein of animum serum, etc. and 0.5-5% polyethylene glycol 2000-20000, etc.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はビオチンの測定法およびこれに用いる測定用試
薬に関し、更に詳細にはアビジンとビオチン化蛋白質を
結合した動物赤血球やプラスチックビーズ等との凝集反
応を遊離のビオチンが阻害することを利用したビオチン
の測定法およびこれに用いる測定用試薬に関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a method for measuring biotin and a measuring reagent used therein, and more specifically, the present invention relates to a method for measuring biotin and a measuring reagent used therein. The present invention relates to a method for measuring biotin that utilizes the fact that free biotin inhibits agglutination reactions, and a measuring reagent used therefor.

〔従来の技術〕[Conventional technology]

ビオチンは生体内の糖質・脂質代謝系等において炭酸固
定および炭酸転移反応に関与しているビタミンであり、
その欠乏症としては痛痒性皮膚炎、舌炎、抑うつ状態等
の報告がある。人におけるビオチン欠乏症は生卵を大量
に摂取したとき以外はほとんど発現しないとされている
が、長期の高カロリー輸液施行患者ではビオチン欠乏症
の報告もあり、これらの患者については、ビオチン量を
測定する必要がある。ビオチン量を測定する方法として
は、血中又は尿中のビオチンを測定することが一般的で
あり、現在、微生物学的定量法が用いられている。
Biotin is a vitamin that is involved in carbonic acid fixation and carbonic acid transfer reactions in the carbohydrate and lipid metabolic systems in living organisms.
Deficiency symptoms such as itchy dermatitis, glossitis, and depression have been reported. Biotin deficiency in humans is said to rarely occur except when large amounts of raw eggs are ingested, but biotin deficiency has also been reported in patients who have undergone long-term high-calorie infusions, so biotin levels should be measured in these patients. There is a need. A common method for measuring the amount of biotin is to measure biotin in blood or urine, and microbiological quantitative methods are currently used.

通常ビオチンは血中では大部分が蛋白質と強固に結合し
ており、血中濃度を測定するためにはまず蛋白質を加水
分解してビオチンを遊離しなければならない。このため
の加水分解の方法としては硫酸による方法、パパインに
よる方法などが用いられている。
Normally, most biotin in blood is tightly bound to proteins, and in order to measure the blood concentration, biotin must first be liberated by hydrolyzing proteins. As a hydrolysis method for this purpose, a method using sulfuric acid, a method using papain, etc. are used.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

しかしながら、微生物学的定量法による正常人の血中ビ
オチンのiは、その加水分解法や定量に用いる菌種など
くよシかなシ異なっていることが知られていた。これは
、菌種によっては結合製ビオチンやビオチン類似物質を
も利用できること、オレイン酸やリノール酸など不飽和
脂肪酸がビオチンの代用になること等の理由によるため
である。
However, it has been known that the i of biotin in the blood of normal people determined by microbiological quantitative methods differs in details such as the hydrolysis method and the bacterial species used for the quantitative determination. This is because, depending on the bacterial species, bound biotin or biotin-like substances can also be used, and unsaturated fatty acids such as oleic acid and linoleic acid can be substituted for biotin.

また微生物学的定量法自体も操作が繁雑であること、測
定結果がでるまでに長時間(24〜72時間)かかるこ
と、検体量が多量(血液1〜2ゴ)に必要なこと等の欠
点があった。したがって、微生物学的定量法にかわる、
容易にかつ正確にビオチン量を測定する方法の開発が要
望されていた。
In addition, the microbiological quantitative method itself has drawbacks such as complicated operations, a long time (24 to 72 hours) before measurement results are available, and the need for a large amount of sample (1 to 2 grams of blood). was there. Therefore, as an alternative to microbiological quantitative methods,
There has been a demand for the development of a method for easily and accurately measuring the amount of biotin.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者はビオチンの測定法に関し、種々研究をおこな
った結果、ビオチンとアビジンの特異的な結合反応を利
用すれば容易かつ正確にビオチン量が測定できることを
見出し、本発明を完成した。
The present inventor conducted various studies regarding methods for measuring biotin, and as a result, discovered that the amount of biotin can be easily and accurately measured by using a specific binding reaction between biotin and avidin, and completed the present invention.

すなわち、本発明はビオチンを含有する被検液中にアビ
ジン及びビオチン化蛋白質結合担体を加え、生じた凝集
をビオチン標準液と比較することを特徴とするビオチン
の測定法及びこれに用いる測定用試薬を提供するもので
ある。
That is, the present invention provides a method for measuring biotin, which is characterized by adding avidin and a biotinylated protein-binding carrier to a biotin-containing test solution, and comparing the resulting aggregation with a biotin standard solution, and a measuring reagent used therefor. It provides:

本発明方法の原理は、ビオチン化した蛋白質を結合した
担体、例えば動物赤血球やグラスチックビーズ等はアビ
ジンを加えることKよシ凝集するが、この凝集反応は遊
離ビオチンの存在により阻害されることを利用してビオ
チン量を測定するというものである。
The principle of the method of the present invention is that carriers bound with biotinylated proteins, such as animal red blood cells and plastic beads, agglutinate when avidin is added, but this agglutination reaction is inhibited by the presence of free biotin. This method is used to measure the amount of biotin.

本発明方法で用いるアビジンは、ニワトリ卵白中に含ま
れる塩基性のアルブミン様結晶タンパク質であ夛、一般
に市販されているものである。また、ビオチン化蛋白質
結合担体は、蛋白質をビオチン化し、更にこれを常法に
よυ担体と結合せしめたものであるが、ビオチン化され
る蛋白質としては、アルブミン、グロブリン、リゾチー
ム等の一般的な蛋白質が挙げられ、また担体としては、
赤血球、プラスチックビーズ(例えば、ポリスチレン、
ポリビニールトルエン、ポリブタジェン等のラテックス
)、ガラスピーズ等が挙げられる。
Avidin used in the method of the present invention is a basic albumin-like crystal protein contained in chicken egg white and is commonly commercially available. In addition, biotinylated protein-bound carriers are obtained by biotinylating proteins and further bonding them to υ carriers using conventional methods.Proteins that can be biotinylated include common proteins such as albumin, globulin, and lysozyme. Examples of carriers include proteins;
Red blood cells, plastic beads (e.g. polystyrene,
Examples include latex such as polyvinyl toluene and polybutadiene), glass beads, and the like.

この担体のうち、赤血球としては特にその動物を選ばず
用いることができるが、特にヒツジ、ニワトリ、ヒトO
盟赤血球等が好ましい。
Among these carriers, any animal can be used as red blood cells, but especially sheep, chicken, human O
Red blood cells and the like are preferred.

蛋白質のビオチン化は、−まず、N−ヒドロキシスクシ
ンイミドビオチン等のビオチン誘導体と蛋白質を溶媒中
で反応せしめ、次いで、反応混合物中から未反応のビオ
チン誘導体を除去することによシおこなわれる。反応に
当ってのピオチン誘導体と蛋白質は、その重量比で1 
; 0.I Sl : 100の範囲、特に1:1〜1
:10の範囲が好ましい。
Biotinylation of proteins is carried out by first reacting a biotin derivative such as N-hydroxysuccinimide biotin with the protein in a solvent, and then removing unreacted biotin derivative from the reaction mixture. The weight ratio of piotin derivative and protein in the reaction is 1.
; 0. I Sl : in the range of 100, especially from 1:1 to 1
: The range of 10 is preferable.

また、反応混合物中から未反応のビオチン誘導体を除去
する方法としては、遠心分離法及び透析法が挙げられる
Furthermore, methods for removing unreacted biotin derivatives from the reaction mixture include centrifugation and dialysis.

ビオチン化蛋白質と担体の結合は公知の方法によシおこ
なうことができるが、この場合の担体とビオチン化蛋白
質の使用量比は、例えばビオチン化牛血清アルブミンと
固定化赤血球を用いた場合、1rn9: 0.02Tn
lS17#: 2d、特に1m1O,1lAt〜1■:
0.5mとすることが好ましい。
Binding of the biotinylated protein and the carrier can be carried out by a known method. In this case, the usage ratio of the carrier and the biotinylated protein is, for example, 1rn9 when biotinylated bovine serum albumin and immobilized red blood cells are used. : 0.02Tn
lS17#: 2d, especially 1m1O, 1lAt~1■:
It is preferable to set it as 0.5m.

本発明方法を実施するKは、アビジンと上記方法によシ
得たビオチン化蛋白質結合担体をとオチンを含有する被
検液に加え、生じた凝集をビオチン標準液と比較すれば
良い。
To perform the method of the present invention, add avidin and the biotinylated protein-bound carrier obtained by the above method to a test solution containing otin, and compare the resulting aggregation with a biotin standard solution.

本発明方法において添加するアビジンは1〜1100n
/lri、ビオチン化蛋白質結合担体は0.1〜IV/
幅、特にアビジンは10−50119/ml、ビオチン
化蛋白質結合担体は0.2〜o、 s V/、esであ
ることが好ましい。
Avidin added in the method of the present invention is 1 to 1100n.
/lri, biotinylated protein-bound carrier is 0.1-IV/
The width is preferably 10-50119/ml for avidin, and 0.2-o, s V/, es for the biotinylated protein-bound carrier.

本発明方法の実施の態様としては、例えば次の方法が挙
げられる。すなわち、96穴U底プレートの各穴に、声
5〜8の0.OIM!Jン酸緩衝生理食塩水CPBS)
を25〜100μ!入れる。次に第1列の穴に検液また
はビオチン標準液25〜100μlを入れ、順次2倍希
釈していく。ついで全ての穴に5〜50 n、jil 
7mlのアビジンPBS溶液25〜100μlおよびビ
オチン化蛋白質結合赤血球の0.1〜0.5%PBS浮
遊液25S100μノを加えて良く混和する。1〜24
時間後に凝集反応をみて、標準液と検液との凝集阻害を
比較し検液のビオチン濃度を求める方法である。
Examples of embodiments of the method of the present invention include the following method. That is, each hole of the 96-hole U-bottom plate has 0. OIM! J acid buffered saline CPBS)
25~100μ! put in. Next, put 25 to 100 μl of the test solution or biotin standard solution into the first row of holes, and sequentially dilute it 2 times. Then apply 5 to 50 n, jil to all holes.
Add 25 to 100 μl of a 7 ml avidin PBS solution and 100 μl of a 0.1 to 0.5% PBS suspension of biotinylated protein-bound red blood cells 25S and mix well. 1-24
In this method, the biotin concentration of the test solution is determined by observing the agglutination reaction after a period of time and comparing the agglutination inhibition between the standard solution and the test solution.

本発明方法においては、非特異的な反応を防ぐため、P
BSに0.05−1%の血清アルブミンや動物血清等の
蛋白質および0.5〜5%のポリエチレングリコール2
000″−20000等を加えることが望ましい。
In the method of the present invention, in order to prevent non-specific reactions, P
BS with 0.05-1% protein such as serum albumin or animal serum and 0.5-5% polyethylene glycol 2
It is desirable to add 000''-20000, etc.

〔発明の効果〕〔Effect of the invention〕

本発明方法によれば必要な検液量は25〜100′μl
であシ、加水分解前の血液量としては実質IOμ!以上
あればビオチン量の測定が可能である。また測定に要す
る時間も微生物学的定量法よシかなシ短縮でき、測定操
作も非常に簡単であるため(1枚の96穴U底プレート
で7検体測定でき、約5分間で定量操作が完了する)、
検液調製後1時間のうちに一人で100検体以上を処理
することができる。したがって本発明は多くの検体を同
時に測定したい場合、例えば輸液施行患者の栄養状態を
モニターする際の血中・尿中ビオチンを測定する場合等
に特に効果がある。
According to the method of the present invention, the required amount of test solution is 25 to 100 μl.
Adashi, the blood volume before hydrolysis is actually IOμ! If the amount is above, it is possible to measure the amount of biotin. In addition, the time required for measurement can be shortened compared to microbiological quantitative methods, and the measurement operation is very simple (7 samples can be measured on one 96-well U-bottom plate, and the quantitative operation can be completed in about 5 minutes. do),
One person can process more than 100 samples within one hour after preparing the test solution. Therefore, the present invention is particularly effective when it is desired to simultaneously measure many specimens, such as when measuring biotin in blood or urine when monitoring the nutritional status of a patient undergoing infusion.

〔実施例〕〔Example〕

次に実施例を挙げて本発明の詳細な説明する。 Next, the present invention will be explained in detail with reference to Examples.

実施例1 ヒオチン化生血清アルブミン(BSA)結合赤血球の作
製: (+)  N−ヒドロキシスクシニイミドビオチン(N
HSビオチン;フナコシ薬品)2■ヲ20μjのジメチ
ルスルホキシドに溶解し、これに1■/MのB S A
 0. I M炭酸水素ナトリウム溶液4dを加えて室
温で4時間反応しBSAをビオチン化した。次に未反応
のNHSピオチンを除くため5倍容のエチルアルコール
を加えて8000 rpmで5分間遠心し上清をすチル
。沈澱物’)4MOPBS (pH7,2)に溶かして
ビオチン化BSAを得た。
Example 1 Preparation of hyotinated live serum albumin (BSA)-conjugated red blood cells: (+) N-hydroxysuccinimide biotin (N
HS biotin (Funakoshi Pharmaceutical) 2. Dissolved in 20 μj of dimethyl sulfoxide, and added 1/M BSA to this.
0. 4 d of IM sodium hydrogen carbonate solution was added and reacted at room temperature for 4 hours to biotinylate BSA. Next, to remove unreacted NHS piotin, 5 times the volume of ethyl alcohol was added, centrifuged at 8000 rpm for 5 minutes, and the supernatant was chilled. The precipitate was dissolved in 4MOPBS (pH 7,2) to obtain biotinylated BSA.

(11)次にヒツジ赤血球をPBSで充分に洗浄後、グ
ルタルアルデヒドを終濃度0.5優に添加して約1時間
室温処理し、PBSで赤血球を洗浄して固定化赤血球を
得た。2.5%固定化赤血球PBS(pf(7,2)浮
遊液40−とビオチン化BSA溶液4ゴとを合わせ、更
にタンニンrR800μgを加えてよく混和し4℃で1
夜放置後PBSで充分に洗浄してビオチン化BSA結合
赤血球を得た。ビオチン化BSA結合赤血球は0.1%
アジ化す) IJウムおよび0、5憾BSAを含むPB
S(pi(6,0)で2幅浮遊液として保存するか、凍
結乾燥して保存し、用時所定の濃度に希釈して使用する
ことができる。
(11) Next, after thoroughly washing the sheep red blood cells with PBS, glutaraldehyde was added to a final concentration of well over 0.5, and the mixture was treated at room temperature for about 1 hour, and the red blood cells were washed with PBS to obtain fixed red blood cells. Combine 2.5% fixed red blood cell PBS (pf(7,2) suspension 40- and biotinylated BSA solution 40-4, add 800 μg of tannin rR, mix well, and incubate at 4°C for 1 hour.
After being left overnight, the cells were thoroughly washed with PBS to obtain biotinylated BSA-conjugated red blood cells. Biotinylated BSA-conjugated red blood cells are 0.1%
PB containing IJum and 0,5 BSA
It can be stored as a two-width suspension at S(pi(6,0)) or lyophilized and diluted to a predetermined concentration before use.

実施例2 ウサギ血中ビオチン濃度の測定: ウサギ血液100μgにパパイン液(シグマP−312
5)20μ/および4.4mMクエン酸−11゜2mM
 NatHPO4緩衝液380μdを混和しトルエン1
滴を加えて37℃で一夜反応後、オートクレーブ(12
1°C110分)処理し8000rpmで5分間の遠心
上清を検液とした。
Example 2 Measurement of biotin concentration in rabbit blood: 100 μg of rabbit blood was added with papain solution (Sigma P-312
5) 20μ/and 4.4mM citric acid-11°2mM
Mix 380 µd of NatHPO4 buffer and add 1 µd of toluene.
After adding drops and reacting overnight at 37°C, autoclave (12
The supernatant obtained by centrifugation at 8000 rpm for 5 minutes was used as the test solution.

96穴U底プレートの各穴に50μjの0.1%BSA
含有PBS(1)H6,O)を入れ、第1列目の穴に検
液またはビオチン標準液(0,8nむ旬)50μlを加
え、順次2倍希釈してゆく、ついで全ての穴に20 n
il/mlのアビジンD(フナコシ薬品)5%PEG6
000含有PBS(pH6,0)溶液50μ!、更に実
施例1で得たビオチン化BSA結合赤血球0.25%浮
遊液(0,1%BSA含有PBS;pH6,o)50μ
lを加えよく混和する。16時間後に凝集反応をみてビ
オチン標準液と検液との凝集阻害を比較し血中ビオチン
濃度を求めたところ0.5 n、Si/mJであった。
50 μj of 0.1% BSA in each well of a 96-well U-bottom plate.
PBS (1) containing PBS (1) H6, O) was added, and 50 μl of the test solution or biotin standard solution (0.8 nm) was added to the first row of holes, and diluted 2 times sequentially. n
il/ml Avidin D (Funakoshi Pharmaceutical) 5% PEG6
000-containing PBS (pH 6,0) solution 50μ! , and further 50μ of the biotinylated BSA-conjugated red blood cell 0.25% suspension obtained in Example 1 (PBS containing 0.1% BSA; pH 6, o).
Add l and mix well. After 16 hours, the agglutination reaction was observed and the agglutination inhibition was compared between the biotin standard solution and the test solution, and the blood biotin concentration was determined to be 0.5 n, Si/mJ.

同一血液2ゴを同様にパパインで加水分解して、微生物
学的定量法によ)血中ビオチン濃度を求めたところ0.
55 n&/rnlであった。本法によシ少量の血液で
従来法とほぼ同様の測定結果が得られた。
Two samples of the same blood were similarly hydrolyzed with papain and the blood biotin concentration was determined using a microbiological quantitative method.
55 n&/rnl. Using this method, almost the same measurement results as the conventional method were obtained using a small amount of blood.

実施例3 ラット血中ビオチン濃度の測定: (1)  ラット血液100μlt−実施例2と同様に
処理して検液を得、アビジン溶液に5 %PEG400
0含有PBS(pH6,0)を用いる以外は全く、実施
例2と同様に操作して18時間後に凝集阻害をみて血中
ビオチン濃度を求めたところing/mであった。同一
血液2−を同様に処理して微生物学的定量法により血中
ビオチン濃度を求めたところ0.97 nji/111
4!であった。
Example 3 Measurement of biotin concentration in rat blood: (1) 100 μlt of rat blood - A test solution was obtained by processing in the same manner as in Example 2, and 5% PEG400 was added to the avidin solution.
The procedure was carried out in the same manner as in Example 2, except that PBS containing 0.0 (pH 6.0) was used, and the blood biotin concentration was determined by checking for inhibition of aggregation after 18 hours and found to be ing/m. When the same blood 2- was treated in the same manner and the blood biotin concentration was determined by microbiological quantitative method, it was 0.97 nji/111
4! Met.

(2)ラット血液200μlに0.05N硫酸600μ
eを加えてオートクレーブ(121°C)で1時間加水
分解し8000rpm5分間の遠心上清をとる。これに
2ゴのジエチルエーテルを加え、良く振盪後エーテル層
を除き、水層に5Mのエチルアルコールを加えて混和後
、8000rpm5分間の遠心上清をとる。これを吸引
乾固し、0.1チBSA含有PBS(粛6,0)200
、tllに溶解して検液とし友。アビジン溶液に2.5
%PEG6000含有PBS(p)16.0)を使う以
外は実施例2と同様に操作し、6時間後に凝集阻害をみ
て血中ビオチン濃度を求めたところin、p/dであっ
た。同一血液2Mを同様に硫酸で加水分解して微生物学
的定量法により血中ビオチン濃度を求めたところ0、9
8 n、@/ atであった。不法により少量の血液で
、パパイン処理法・硫酸処理法とも従来法とほぼ同じ測
定結果が得られた。
(2) 600 μl of 0.05N sulfuric acid in 200 μl of rat blood
Add e and hydrolyze in an autoclave (121°C) for 1 hour, centrifuge at 8000 rpm for 5 minutes, and collect the supernatant. Add 2 portions of diethyl ether, shake well, remove the ether layer, add 5M ethyl alcohol to the aqueous layer, mix, and centrifuge at 8000 rpm for 5 minutes to collect the supernatant. This was sucked to dryness, and PBS containing 0.1 h BSA (6,0%) was added to the
, dissolve in tll and use as a test solution. 2.5 in avidin solution
The procedure was carried out in the same manner as in Example 2 except that PBS (p) containing % PEG6000 (p16.0) was used, and the blood biotin concentration was determined by observing the inhibition of aggregation after 6 hours, and it was found to be in, p/d. When 2M of the same blood was similarly hydrolyzed with sulfuric acid and the blood biotin concentration was determined using a microbiological quantitative method, it was found to be 0.9.
8 n, @/at. Both papain and sulfuric acid treatment methods obtained almost the same measurement results as the conventional method using illegally small amounts of blood.

実施例4 ヒト尿中ビオチン濃度の測定: ヒト尿(2検体)を0.1%BSA含有PBS(1)H
6,0)で25倍希釈して検液とした、アビジン溶液K
PBS(pH6,0)を使つ以外ハ実施j例2と全く同
様に操作して、2時間後に凝集阻害をみて尿中ビオチン
濃度を求めたところ、検体■20 n9/rn1%検体
■8 n、F /ml テh ッfc。同−尿2検体を
微生物学定量法にょシビオチン濃度を測定したところ、
検体■21.Onυ堀、検体■10.1 n777mで
あった。不法にょシ短時間で従来法とほぼ同様の測定結
果が得られた。
Example 4 Measurement of biotin concentration in human urine: Human urine (2 samples) was dissolved in PBS(1)H containing 0.1% BSA.
Avidin solution K diluted 25 times with 6,0) and used as a test solution
The procedure was carried out in exactly the same manner as in Example 2 except for using PBS (pH 6,0), and the urine biotin concentration was determined by observing the inhibition of aggregation after 2 hours. , F/ml teh fc. The biotin concentration of the same two urine samples was measured using the microbiological quantitative method.
Specimen ■21. Onυ moat, sample ■10.1 n777m. Almost the same measurement results as the conventional method were obtained in a short time.

実施例5 ビオチン濃度測定用試薬: 下に示す試薬1〜4を調製し、常法に従い凍結乾燥し、
各々バイアルに充填した。
Example 5 Reagent for measuring biotin concentration: Reagents 1 to 4 shown below were prepared, freeze-dried according to a conventional method,
Each was filled into a vial.

試薬1(ビオチン標準品) 試薬2(アビジン) 試薬3(ビオチン化BSA結合赤血球)試゛薬4(検体
希釈液) 1塩化ナトリウム      438.3■上記試薬は
、96穴U底プレー)10枚分てちゃ、それぞれ用時に
1祷、50mJ、5050−15Qの蒸留水に溶解せし
める。なお、試薬2が溶解しにくい場合、湯浴で加温す
れば容易に  ′溶解する。
Reagent 1 (biotin standard) Reagent 2 (avidin) Reagent 3 (biotinylated BSA-conjugated red blood cells) Reagent 4 (sample dilution solution) 1 Sodium chloride 438.3 ■ The above reagents are for 10 plates (96-well U-bottom plate) Before use, dissolve each in 50 mJ of distilled water, 5050-15Q. Note that if Reagent 2 is difficult to dissolve, it can be easily dissolved by heating it in a hot water bath.

以上that's all

Claims (1)

【特許請求の範囲】 1、ビオチンを含有する被検液中にアビジン及びビオチ
ン化蛋白質結合担体を加え、生じた凝集をビオチン標準
液と比較することを特徴とするビオチンの測定法。 2、アビジン及びビオチン化蛋白質結合担体を含有する
ビオチン測定用試薬。
[Scope of Claims] 1. A method for measuring biotin, which comprises adding avidin and a biotinylated protein-binding carrier to a biotin-containing test solution, and comparing the resulting aggregation with a biotin standard solution. 2. A biotin measurement reagent containing avidin and a biotinylated protein-binding carrier.
JP19429884A 1984-09-17 1984-09-17 Measurement of biotin and measuring agent therefor Pending JPS6171359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19429884A JPS6171359A (en) 1984-09-17 1984-09-17 Measurement of biotin and measuring agent therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19429884A JPS6171359A (en) 1984-09-17 1984-09-17 Measurement of biotin and measuring agent therefor

Publications (1)

Publication Number Publication Date
JPS6171359A true JPS6171359A (en) 1986-04-12

Family

ID=16322267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19429884A Pending JPS6171359A (en) 1984-09-17 1984-09-17 Measurement of biotin and measuring agent therefor

Country Status (1)

Country Link
JP (1) JPS6171359A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362624A (en) * 1988-05-25 1994-11-08 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable reaction vessel therefor
JP2002365298A (en) * 2001-06-08 2002-12-18 Tosoh Corp Measurement inhibition reducing method and reagent composition
JP2007127543A (en) * 2005-11-04 2007-05-24 Kose Corp Method for evaluating horny layer retention of external drug product

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5830667A (en) * 1981-08-05 1983-02-23 エフ・ホフマン−ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト Marked immunologic active substance

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5830667A (en) * 1981-08-05 1983-02-23 エフ・ホフマン−ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト Marked immunologic active substance

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362624A (en) * 1988-05-25 1994-11-08 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable reaction vessel therefor
JP2002365298A (en) * 2001-06-08 2002-12-18 Tosoh Corp Measurement inhibition reducing method and reagent composition
JP2007127543A (en) * 2005-11-04 2007-05-24 Kose Corp Method for evaluating horny layer retention of external drug product
JP4690174B2 (en) * 2005-11-04 2011-06-01 株式会社コーセー Method for evaluating stratum corneum retention of external preparations

Similar Documents

Publication Publication Date Title
Vaishya et al. Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice
JPS6367864B2 (en)
DK174032B1 (en) Kit as well as immunometric dosing method that can be applied to whole cells
DE2840768A1 (en) IMMUNOLOGICAL REAGENT
EP0032204B1 (en) Process and reagent for the immunological determination of enzymes
NL8200587A (en) METHOD FOR AN IMMUNOCHEMICAL ENZYME DETERMINATION.
US3562384A (en) Immunological indicator and test system
JPH10160734A (en) Mixture for calibration/control for immunoassay
CN109917138A (en) A kind of myoglobins time-resolved fluoroimmunoassay measurement in chromatography kit
CN109521200A (en) It is a kind of while detecting the kit of Multiple components content, method and its application in blood plasma
JPS6171359A (en) Measurement of biotin and measuring agent therefor
EP0079145A1 (en) Reagent for use in diagnosis of syphilis and preparation thereof
JPS634147B2 (en)
CN114778823A (en) Determination reagent, kit and quantitative method for human asialoglycoprotein receptor
USRE28548E (en) Method and reagents for the diagnosis of viral diseases
JP2508915B2 (en) Anti-SSA / Ro and SSB / La antibody measuring antigen, method for producing the same, and anti-SSA / Ro and SSB / La antibody measuring method
CN108089014A (en) A kind of parathyroid hormone immue quantitative detection reagent box and preparation method thereof
JPS5995460A (en) Method and kit for diagnosing rheumatic sickness
CN110117648A (en) Circadian rhythm sleep obstacle biomarker
RU2752766C1 (en) Method for determining immunological tolerance in animals
CN109060781B (en) Method for detecting anti-lecithin antibody in serum
JPS61149863A (en) Measuring method of biotin and reagent for measurement to be used therein
EP1861705B1 (en) Method for determining an allergic response
JP4045558B2 (en) Anti-gelatin antibody assay
SU594173A1 (en) Method of obtaining antigen for diagnosis of birds pullorosa typhus